Cerebral small vessel disease and why it's so important

Written in association with: Professor Hedley Emsley
Published: | Updated: 04/06/2024
Edited by: Karolyn Judge

Even though cerebral small vessel disease is very common, you may never have heard of it. It affects most older people but should not be thought of as part of the normal ageing process. It can also be seen in younger adults.

 

It’s entirely possible to have it yet not know about it. Very often small vessel disease goes undetected. But if it is identified then it's sensible to think about how to reduce the risk of it causing future problems.

 

Here to provide an in-depth look at this condition is leading consultant neurologist and vascular neurology specialist Professor Hedley Emsley.

Model of brain, which can be affected by cerebral small vessel disease

   

What is small vessel disease?

Small vessel disease is the most common form of cerebrovascular disease, that is, blood vessel disease of the brain. Damaged small blood vessels in the brain can cause white matter lesions and other signs that are seen on brain scans. Small vessel disease is often caused by high blood pressure and diabetes mellitus, but there is a number of other causes.

What problems can it cause?

Small vessel disease causes around a quarter of all strokes. But stroke is the tip of the iceberg. Small vessel disease is also the second most common cause of dementia. And there are many more people with small vessel disease who will gradually develop problems such as difficulties with thinking or walking.

 

 

What is small vessel disease not?

Although small vessel disease can cause stroke, it’s not always appropriate to automatically label someone with small vessel disease on a scan as having had a stroke. Stroke is a clinical event causing a sudden loss of function such as weakness or loss of speech. People labelled incorrectly with stroke can face unnecessary difficulties with issues such as driving and insurance, or may worry unnecessarily.

 

 

How is small vessel disease identified?

Small vessel disease may be identified as a result of someone having a stroke or developing dementia. Otherwise, it tends to be identified on a brain scan. Signs of small vessel disease are often picked up on brain scans done for other reasons. For example, most brain scans performed for headache don’t show any sinister cause. But scans often show incidental findings, and small vessel disease is the commonest of these, particularly in older adults.

 

 

What is done once small vessel disease has been found?

Very often, not much. By comparison with what might happen if a small cyst or benign tumour is found on a brain scan, when people will usually be referred on and have further scans, small vessel disease on a brain scan often doesn’t trigger any action. This can be the case even if the small vessel disease is quite severe. This is a pity because the opportunity to reduce the likelihood of future problems from small vessel disease may be missed. 

 

 

What should be done?

Right now, clinical services tend to be organised around the complications of small vessel disease such as stroke or dementia. More needs to be done to make the most of opportunities for prevention and to ensure appropriate treatment. It’s important to consider the type of small vessel disease. Most cases will be due to vascular risk factors such as high blood pressure. But there are other conditions such as cerebral amyloid angiopathy, genetic disorders or other causes, which are often managed differently.

 

 

What can you do about it yourself?

It's sensible to maintain a healthy lifestyle, avoid being overweight, taking regular exercise and eating a healthy diet. If you smoke, it’s sensible to stop. It’s also sensible to make sure that treatable conditions such as high blood pressure are recognised and treated and to make sure conditions such as diabetes mellitus and high cholesterol are under control.

 

 

 

If you require expert neurological treatment for cerebral small vessel disease, arrange a consultation with Professor Emsley via his Top Doctors profile.

By Professor Hedley Emsley
Neurology

Professor Hedley Emsley is a renowned consultant neurologist practising privately at the Greater Lancashire Hospital in Preston. His areas of expertise include vascular neurologystrokecerebrovascular disease (including small vessel disease, cerebral amyloid angiopathy)late-onset epilepsymigraine and neurological disorders including Parkinson’s disease.

Professor Emsley graduated with an MBChB in 1996 from the University of Manchester. He undertook several junior doctor posts in the North West of England and at the National Hospital for Neurology and Neurosurgery in London before becoming a member of the Royal College of Physicians of London (MRCP) in 1999. He then completed a PhD on inflammation and cytokine regulation in stroke, awarded in 2004, and undertook specialist training as a clinical lecturer in neurology at the Walton Centre for Neurology & Neurosurgery in Liverpool. Before becoming a fellow of the Royal College of Physicians of London (FRCP) in 2012, he obtained both the Certificate of Completion of Training (CCT) in neurology and a postgraduate certificate in clinical education in 2008 (PGCTLCP with distinction). He was made a fellow of the Higher Education Academy (FHEA) in 2012.

Professor Emsley was appointed Consultant Neurologist with special interest in Stroke Neurology at Lancashire Teaching Hospitals NHS Foundation Trust in 2008, and in 2014, he became the Clinical Director for Neurology at the Trust for three years. He has numerous external responsibilities including his current roles on the Epilepsy Research Institute’s Mortality, Morbidity and Risk Task Force, the Association of British Neurologists Advisory Group on Data and Devices, and on the Health Data Research UK (HDR-UK) North Executive Committee. Previous roles include co-chair for the Association of British Neurologists Stroke Advisory Group, clinical advisor to the Neurology Intelligence Collaborative, North West National Institute for Health Research (NIHR) advisory panel member for the Research for Patient Benefit (RfPB) programme, and external examiner for the University College London Stroke MSc programme.

He took up his post as Professor of Clinical Neuroscience at Lancaster University in 2017 alongside his NHS role. He has authored or co-authored more than 200 academic outputs in all including articles in peer-reviewed medical journals, reports, book chapters and conference abstracts. He regularly engages in peer-review and editorial work. He is a chief investigator and a research supervisor on a range of NIHR portfolio studies in stroke and neurological disorders. He has extensive research collaborations and a number of research interests including cerebrovascular disease and its interface with other neurological disorders, inflammation, infection, novel mechanisms, targets, biomarkers and trials in cerebrovascular disease and other neurological disorders, as well as novel uses of routinely collected data. He also serves on Lancaster University’s Research Ethics Committee.

Current collaborations and projects include:

  • work with academic partners on NHS England’s North West Secure Data Environment, a secure data and research analysis platform, including funding to support work on artificial intelligence related work on routinely collected data
  • a collaboration with the Department of Health & Social Care using Hospital Episodes Statistics Data on neurological admissions, comorbidities, including work that has highlighted the prominence of cardiovascular disease as a comorbidity in epilepsy
  • a forthcoming book chapter on Epilepsy in Older Adults in the new edition of leading reference in the field of geriatric care, Brocklehurst's Textbook of Geriatric Medicine and Gerontology
  • establishment of a Collaboration for Late Onset and Vascular Epilepsy Research (CLOVER) in the UK and with international partners
  • work as part on the International Small Vessel Disease Network led by the University of Edinburgh to improve clinical SVD care

View Profile

Overall assessment of their patients


  • Related procedures
  • Botulinum toxin (Botox™)
    Neuropsychology
    Sleep disorders
    Learning disabilities
    Tinnitus
    Obstructive sleep apnea
    Neurological treatments
    Chronic headache
    Neuropathic pain
    Epilepsy
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.